Clinical Trials Logo

Clinical Trial Summary

To compare the rate and extent of absorption of cabergoline 0.5 mg tablets (test) versus Dostinex (reference)


Clinical Trial Description

To compare the rate and extent of absorption of cabergoline 0.5 mg tablets (test) versus Dostinex (reference) administered as 2 x 0.5 mg tablets under fed conditions. ;


Study Design


Related Conditions & MeSH terms


NCT number NCT00652873
Study type Interventional
Source Par Pharmaceutical, Inc.
Contact
Status Completed
Phase Phase 1
Start date July 2001
Completion date December 2001

See also
  Status Clinical Trial Phase
Completed NCT00652600 - Bioavailability Study of Propranolol Under Fed Conditions Phase 1
Completed NCT01380496 - Bioequivalence Study of Doxycycline Monohydrate Tablets Under Fed Conditions Phase 1
Completed NCT00652821 - Bioavailability Study of Tramadol/APAP Tablets Under Fed Conditions Phase 1
Completed NCT00652704 - Bioavailability Study of Doxycycline Monohydrate Capsules and Monodox Under Fasting and Fed Conditions Phase 1
Completed NCT00652730 - Bioavailability Study of (Buspar) Buspirone HCl Tablets Under Fasting and Fed Conditions Phase 1
Completed NCT05337969 - The Study Aims to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Assessed. N/A
Completed NCT05329857 - The Study Intends to Show Bioequivalence of the Test Product and the Reference Reference Product in a Crossover Design Study Healthy Volunteers. Additionally, the Safety Profile of Test Product Compared to Reference Product Will be Evaluated. N/A
Completed NCT00653003 - Bioavailability Study of Leflunomide Tablets Under Fed Conditions Phase 1
Completed NCT01380431 - A Comparative Bioavailability Study of Lisinopril Tablets, 40 mg - Effect of Food Study Phase 1